Henry Douglas Robb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henry Douglas Robb has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Bibek Das
Department of Surgery and Cancer, Imperial College London, London, United Kingdom
2 shared publications - Christos Kontovounisios
Department of Surgery and Cancer, South Kensington Campus, Imperial College London, London SW7 2AZ, UK
2 shared publications Hutan Ashrafian
2 shared publications- Matyas Fehervari
Department of Bariatric Surgery, Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom
2 shared publications - Piers R. Boshier
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK
2 shared publications - Aksaan Arif
Faculty of Medicine, Imperial College School of Medicine, London, UK
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Pancreatic exocrine function following bariatric surgery: a systematic review and meta-analysis
- 7 November 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Open AccessPancreatic exocrine function following bariatric surgery: a systematic review and meta-analysis
- Open Access
- 5 August 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
The influence of hypoxia on cancer lipid metabolism: a scoping review
Background: Hypoxia, a hallmark of solid tumours, profoundly alters cellular metabolism to enable survival in the harsh tumour microenvironment. Whilst effects on carbohydrate and protein metabolism are well characterised, the hypoxic regulation of lipid metabolism remains poorly understood. Recent advances in lipidomics have revealed that lipids not only serve as energy resources, but have critical roles in oncogenic signalling, cell homeostasis and membrane metabolism. Understanding hypoxia-driven lipid reprogramming could uncover new therapeutic opportunities. Methods: A scoping review was conducted following internationally accepted guidelines and reported using the PRISMA-ScR Checklist. MEDLINE, Embase, and Web of Science were searched from inception to 31st August 2025 using tailored strategies, supplemented with grey literature and reference snowballing. Eligible studies included original peer-reviewed research investigating hypoxia and lipid metabolism in cancer using in vitro, in vivo, or human models with physiologically relevant hypoxic conditions. Data were extracted and thematically analysed across four domains: lipid accumulation, lipolysis, membrane metabolism, and lipid signalling. Results: From 4632 records identified, 53 studies met the inclusion criteria. Most investigations used immortalised 2D cancer cell lines exposed to chronic, moderate hypoxia (1–2% O₂). Thematic analysis revealed that the majority of studies focused on lipid accumulation, particularly through lipid droplet formation, de novo lipogenesis, and exogenous lipid uptake. Lipolysis, membrane metabolism, and lipid signalling under hypoxic conditions were less frequently examined. Together, these findings highlight a predominant emphasis on lipid storage pathways, with comparatively limited exploration of lipid degradation and signalling processes. A narrative synthesis summarised key mechanisms, identified major knowledge gaps, and outlined emerging therapeutic opportunities in hypoxia-driven lipid metabolism. Conclusions: Hypoxia drives diverse, cancer-specific lipidomic adaptations that promote survival and treatment resistance. Although limitations in current models and experimental conditions constrain translation, advancing our understanding of hypoxia-driven lipid reprogramming presents promising avenues for therapeutic development and clinical application.
- 5 August 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Open AccessThe influence of hypoxia on cancer lipid metabolism: a scoping review
Background: Hypoxia, a hallmark of solid tumours, profoundly alters cellular metabolism to enable survival in the harsh tumour microenvironment. Whilst effects on carbohydrate and protein metabolism are well characterised, the hypoxic regulation of lipid metabolism remains poorly understood. Recent advances in lipidomics have revealed that lipids not only serve as energy resources, but have critical roles in oncogenic signalling, cell homeostasis and membrane metabolism. Understanding hypoxia-driven lipid reprogramming could uncover new therapeutic opportunities. Methods: A scoping review was conducted following internationally accepted guidelines and reported using the PRISMA-ScR Checklist. MEDLINE, Embase, and Web of Science were searched from inception to 31st August 2025 using tailored strategies, supplemented with grey literature and reference snowballing. Eligible studies included original peer-reviewed research investigating hypoxia and lipid metabolism in cancer using in vitro, in vivo, or human models with physiologically relevant hypoxic conditions. Data were extracted and thematically analysed across four domains: lipid accumulation, lipolysis, membrane metabolism, and lipid signalling. Results: From 4632 records identified, 53 studies met the inclusion criteria. Most investigations used immortalised 2D cancer cell lines exposed to chronic, moderate hypoxia (1–2% O₂). Thematic analysis revealed that the majority of studies focused on lipid accumulation, particularly through lipid droplet formation, de novo lipogenesis, and exogenous lipid uptake. Lipolysis, membrane metabolism, and lipid signalling under hypoxic conditions were less frequently examined. Together, these findings highlight a predominant emphasis on lipid storage pathways, with comparatively limited exploration of lipid degradation and signalling processes. A narrative synthesis summarised key mechanisms, identified major knowledge gaps, and outlined emerging therapeutic opportunities in hypoxia-driven lipid metabolism. Conclusions: Hypoxia drives diverse, cancer-specific lipidomic adaptations that promote survival and treatment resistance. Although limitations in current models and experimental conditions constrain translation, advancing our understanding of hypoxia-driven lipid reprogramming presents promising avenues for therapeutic development and clinical application.
- 17 January 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (3) , 111412
Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework
- 17 January 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (3) , 111412
Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework
- Open Access
- 1 January 2026
- Published by S. Karger AG in European Surgical Research
- Vol. 67 (1) , 107-116
Does Treatment of Jaundice Matter before Pancreaticoduodenectomy? Results from an International Multicentre Recurrence after Whipple (RAW) Study
Introduction: The management of jaundice before pancreaticoduodenectomy (PD) remains controversial. We aimed to analyse the clinical outcomes of jaundiced patients in a large cohort of PD patients stratified by treatment pathway. Methods: Data were collected from the Recurrence After Whipple’s (RAW) study – an international, multicentre, retrospective cohort study of PD patients. Patients that underwent PD with subsequent histology confirmed pancreatic head ductal adenocarcinoma, ampullary adenocarcinoma, and distal cholangiocarcinoma were included in the RAW study. Patients were stratified into three groups by management of preoperative jaundice. Results: Patients (n = 1,172) were classified into three groups: surgery while jaundiced (n = 109), surgery after successful preoperative biliary drainage (PBD) (n = 777), and not jaundiced (n = 286). Jaundice was an independent predictor of poor survival, whether treated (HR 1.45, CI 1.20–1.76) or untreated (HR 1.55, CI 1.16–2.09) pre-operatively. On multivariate analysis, PBD was associated with improved disease-free survival (HR 0.75, CI 0.58–0.97) but not overall survival (HR 0.93, CI 0.72–1.20) relative to the untreated jaundiced population. PBD was associated with a reduced, but statistically nonsignificant, risk of PD-related complications (OR 0.63 CI 0.39–1.02; p = 0.059). Conclusion: We observed a nonsignificant trend towards reduced perioperative complications and improved disease-free survival following PBD prior to PD.
- 1 January 2026
- Published by S. Karger AG in European Surgical Research
- Vol. 67 (1) , 107-116
Open AccessDoes Treatment of Jaundice Matter before Pancreaticoduodenectomy? Results from an International Multicentre Recurrence after Whipple (RAW) Study
Introduction: The management of jaundice before pancreaticoduodenectomy (PD) remains controversial. We aimed to analyse the clinical outcomes of jaundiced patients in a large cohort of PD patients stratified by treatment pathway. Methods: Data were collected from the Recurrence After Whipple’s (RAW) study – an international, multicentre, retrospective cohort study of PD patients. Patients that underwent PD with subsequent histology confirmed pancreatic head ductal adenocarcinoma, ampullary adenocarcinoma, and distal cholangiocarcinoma were included in the RAW study. Patients were stratified into three groups by management of preoperative jaundice. Results: Patients (n = 1,172) were classified into three groups: surgery while jaundiced (n = 109), surgery after successful preoperative biliary drainage (PBD) (n = 777), and not jaundiced (n = 286). Jaundice was an independent predictor of poor survival, whether treated (HR 1.45, CI 1.20–1.76) or untreated (HR 1.55, CI 1.16–2.09) pre-operatively. On multivariate analysis, PBD was associated with improved disease-free survival (HR 0.75, CI 0.58–0.97) but not overall survival (HR 0.93, CI 0.72–1.20) relative to the untreated jaundiced population. PBD was associated with a reduced, but statistically nonsignificant, risk of PD-related complications (OR 0.63 CI 0.39–1.02; p = 0.059). Conclusion: We observed a nonsignificant trend towards reduced perioperative complications and improved disease-free survival following PBD prior to PD.
- Open Access
- 26 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (5) , 3159-3168
How is 3D modeling in metabolic surgery utilized and what is its clinical benefit: a systematic review and meta-analysis
Background: Three-dimensional (3D) modeling is an emerging technology in surgery, with applications in operative planning, surgical education, and patient engagement. Metabolic surgery, the most effective treatment for obesity, is increasingly prevalent leading to new complex clinical challenges. This systematic review aims to understand the use of 3D modeling in metabolic surgery and its impact on clinical outcomes. Methods: Following a registered protocol (PROSPERO: CRD42024545311), a comprehensive search using MEDLINE, Embase, and CENTRAL Cochrane Library was conducted. Eligible papers underwent screening and full-text review. A qualitative thematic analysis was performed alongside meta-analyses on available volumetric data. Results were reported as directed by the PRISMA guidelines. Results: Twenty-nine studies were included, with most at Level II evidence (n = 19, 66%). Studies focused on operative planning and surgical practice (90%, n = 26) and were subdivided into preoperative planning (14%, n = 4), postoperative diagnosis (31%, n = 9), and postoperative assessment and prediction (45%, n = 13). Only three papers addressed surgical education (10%). 3D modeling for patient education was unexplored. To assess 3D modeling’s cross-study consistency, pooled meta-analyses on preoperative and postoperative 3D gastric volumetry and abdominal circumference were performed. Average preoperative stomach volume was 794.93 mL (95% confidence interval [CI]: 518.61–1071.26 mL). Postoperative LSG and RYGB/OAGB gastric volumes were 171.71 mL (95% CI: 113.37–288.58 mL) and 35.73 mL (95% CI: 29.32–42.14 mL) respectively. Average abdominal circumference was 120.04 cm (95% CI: 100.72–139.35 cm). All volumes were consistent with published data. Conclusions: This systematic review highlighted the accuracy of 3D modeling for volumetric assessments and its developing role in surgical planning and training. However, its potential benefits in AR or 3DP models, in patient education or for answering bariatric surgical debates using 3D volumetric studies remain underutilized.
- 26 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (5) , 3159-3168
Open AccessHow is 3D modeling in metabolic surgery utilized and what is its clinical benefit: a systematic review and meta-analysis
Background: Three-dimensional (3D) modeling is an emerging technology in surgery, with applications in operative planning, surgical education, and patient engagement. Metabolic surgery, the most effective treatment for obesity, is increasingly prevalent leading to new complex clinical challenges. This systematic review aims to understand the use of 3D modeling in metabolic surgery and its impact on clinical outcomes. Methods: Following a registered protocol (PROSPERO: CRD42024545311), a comprehensive search using MEDLINE, Embase, and CENTRAL Cochrane Library was conducted. Eligible papers underwent screening and full-text review. A qualitative thematic analysis was performed alongside meta-analyses on available volumetric data. Results were reported as directed by the PRISMA guidelines. Results: Twenty-nine studies were included, with most at Level II evidence (n = 19, 66%). Studies focused on operative planning and surgical practice (90%, n = 26) and were subdivided into preoperative planning (14%, n = 4), postoperative diagnosis (31%, n = 9), and postoperative assessment and prediction (45%, n = 13). Only three papers addressed surgical education (10%). 3D modeling for patient education was unexplored. To assess 3D modeling’s cross-study consistency, pooled meta-analyses on preoperative and postoperative 3D gastric volumetry and abdominal circumference were performed. Average preoperative stomach volume was 794.93 mL (95% confidence interval [CI]: 518.61–1071.26 mL). Postoperative LSG and RYGB/OAGB gastric volumes were 171.71 mL (95% CI: 113.37–288.58 mL) and 35.73 mL (95% CI: 29.32–42.14 mL) respectively. Average abdominal circumference was 120.04 cm (95% CI: 100.72–139.35 cm). All volumes were consistent with published data. Conclusions: This systematic review highlighted the accuracy of 3D modeling for volumetric assessments and its developing role in surgical planning and training. However, its potential benefits in AR or 3DP models, in patient education or for answering bariatric surgical debates using 3D volumetric studies remain underutilized.
- Open Access
- 11 March 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (8) , 5907-5920
The current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review
Background: 3D reconstruction technology could revolutionise medicine. Within surgery, 3D reconstruction has a growing role in operative planning and procedures, surgical education and training as well as patient engagement. Whilst virtual and 3D printed models are already used in many surgical specialities, oesophagogastric surgery has been slow in their adoption. Therefore, the authors undertook a scoping review to clarify the current and future roles of 3D modelling in oesophagogastric surgery, highlighting gaps in the literature and implications for future research.Methods: A scoping review protocol was developed using a comprehensive search strategy based on internationally accepted guidelines and tailored for key databases (MEDLINE, Embase, Elsevier Scopus and ISI Web of Science). This is available through the Open Science Framework (osf.io/ta789) and was published in a peer-reviewed journal. Included studies underwent screening and full text review before inclusion. A thematic analysis was performed using pre-determined overarching themes: (i) surgical training and education, (ii) patient education and engagement, and (iii) operative planning and surgical practice. Where applicable, subthemes were generated.Results: A total of 56 papers were included. Most research was low-grade with 88% (n = 49) of publications at or below level III evidence. No randomised control trials or systematic reviews were found. Most literature (86%,n = 48) explored 3D reconstruction within operative planning. These were divided into subthemes of pre-operative (77%,n = 43) and intra-operative guidance (9%,n = 5). Few papers reported on surgical training and education (14%,n = 8), and were evenly subcategorised into virtual reality simulation (7%,n = 4) and anatomical teaching (7%,n = 4). No studies utilising 3D modelling for patient engagement and education were found.Conclusion: The use of 3D reconstruction is in its infancy in oesophagogastric surgery. The quality of evidence is low and key themes, such as patient engagement and education, remain unexplored. Without high quality research evaluating the application and benefits of 3D modelling, oesophagogastric surgery may be left behind.
- 11 March 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (8) , 5907-5920
Open AccessThe current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review
Background: 3D reconstruction technology could revolutionise medicine. Within surgery, 3D reconstruction has a growing role in operative planning and procedures, surgical education and training as well as patient engagement. Whilst virtual and 3D printed models are already used in many surgical specialities, oesophagogastric surgery has been slow in their adoption. Therefore, the authors undertook a scoping review to clarify the current and future roles of 3D modelling in oesophagogastric surgery, highlighting gaps in the literature and implications for future research.Methods: A scoping review protocol was developed using a comprehensive search strategy based on internationally accepted guidelines and tailored for key databases (MEDLINE, Embase, Elsevier Scopus and ISI Web of Science). This is available through the Open Science Framework (osf.io/ta789) and was published in a peer-reviewed journal. Included studies underwent screening and full text review before inclusion. A thematic analysis was performed using pre-determined overarching themes: (i) surgical training and education, (ii) patient education and engagement, and (iii) operative planning and surgical practice. Where applicable, subthemes were generated.Results: A total of 56 papers were included. Most research was low-grade with 88% (n = 49) of publications at or below level III evidence. No randomised control trials or systematic reviews were found. Most literature (86%,n = 48) explored 3D reconstruction within operative planning. These were divided into subthemes of pre-operative (77%,n = 43) and intra-operative guidance (9%,n = 5). Few papers reported on surgical training and education (14%,n = 8), and were evenly subcategorised into virtual reality simulation (7%,n = 4) and anatomical teaching (7%,n = 4). No studies utilising 3D modelling for patient engagement and education were found.Conclusion: The use of 3D reconstruction is in its infancy in oesophagogastric surgery. The quality of evidence is low and key themes, such as patient engagement and education, remain unexplored. Without high quality research evaluating the application and benefits of 3D modelling, oesophagogastric surgery may be left behind.
- Open Access
Current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review protocol
Introduction Three-dimensional (3D) reconstruction describes the generation of either virtual or physically printed anatomically accurate 3D models from two-dimensional medical images. Their implementation has revolutionised medical practice. Within surgery, key applications include growing roles in operative planning and procedures, surgical education and training, as well as patient engagement and education. In comparison to other surgical specialties, oesophagogastric surgery has been slow in their adoption of this technology. Herein the authors outline a scoping review protocol that aims to analyse the current role of 3D modelling in oesophagogastric surgery and highlight any unexplored avenues for future research. Methods and analysis The protocol was generated using internationally accepted methodological frameworks. A succinct primary question was devised, and a comprehensive search strategy was developed for key databases (MEDLINE, Embase, Elsevier Scopus and ISI Web of Science). These were searched from their inception to 1 June 2020. Reference lists will be reviewed by hand and grey literature identified using OpenGrey and Grey Literature Report. The protocol was registered to the Open Science Framework (osf.io/ta789). Two independent reviewers will screen titles, abstracts and perform full-text reviews for study selection. There will be no methodological quality assessment to ensure a full thematic analysis is possible. A data charting tool will be created by the investigatory team. Results will be analysed to generate descriptive numerical tabular results and a thematic analysis will be performed. Ethics and dissemination Ethical approval was not required for the collection and analysis of the published data. The scoping review report will be disseminated through a peer-reviewed publication and international conferences. Registration details The scoping review protocol has been registered on the Open Science Framework (https://osf.io/ta789).
Open AccessCurrent and possible future role of 3D modelling within oesophagogastric surgery: a scoping review protocol
Introduction Three-dimensional (3D) reconstruction describes the generation of either virtual or physically printed anatomically accurate 3D models from two-dimensional medical images. Their implementation has revolutionised medical practice. Within surgery, key applications include growing roles in operative planning and procedures, surgical education and training, as well as patient engagement and education. In comparison to other surgical specialties, oesophagogastric surgery has been slow in their adoption of this technology. Herein the authors outline a scoping review protocol that aims to analyse the current role of 3D modelling in oesophagogastric surgery and highlight any unexplored avenues for future research. Methods and analysis The protocol was generated using internationally accepted methodological frameworks. A succinct primary question was devised, and a comprehensive search strategy was developed for key databases (MEDLINE, Embase, Elsevier Scopus and ISI Web of Science). These were searched from their inception to 1 June 2020. Reference lists will be reviewed by hand and grey literature identified using OpenGrey and Grey Literature Report. The protocol was registered to the Open Science Framework (osf.io/ta789). Two independent reviewers will screen titles, abstracts and perform full-text reviews for study selection. There will be no methodological quality assessment to ensure a full thematic analysis is possible. A data charting tool will be created by the investigatory team. Results will be analysed to generate descriptive numerical tabular results and a thematic analysis will be performed. Ethics and dissemination Ethical approval was not required for the collection and analysis of the published data. The scoping review report will be disseminated through a peer-reviewed publication and international conferences. Registration details The scoping review protocol has been registered on the Open Science Framework (https://osf.io/ta789).